Council on the Kidney in Cardiovascular Disease (KCVD)

Message from the Chair

Alexander Staruschenko, PhD, FAHA

Welcome to the Council for the Kidney in Cardiovascular Disease (KCVD). Our Council strives to reduce cardiovascular-related disability and death through clinical, translational, and basic research, communication, advocacy and education relevant to: a) the role of the kidney in hypertension, b) the role of the kidney in cardiovascular diseases – this includes acute kidney injury and chronic kidney disease and its effects on heart disease, stroke, and peripheral vascular disease, c) the specific role of the kidney in diabetes-induced cardiovascular disease, and d) cardio-renal syndrome.

Alexander Staruschenko, PhD, FAHA
Chair, Council on Kidney in Cardiovascular Disease

Hypertension Scientific Sessions 2021

Sept. 27–29, 2021
A Virtual Event

Scientific Sessions 2021

November 13-15, 2021
Boston, MA + Virtual

black male doctor

AHA Professional Members are Difference Makers

research

Funding Opportunities

The method for applying for funding is Web-based, using our electronic system, ProposalCentral.


Hypertension Journal cover

Hypertension

Hypertension is one of 11 AHA journals. It represents the Councils on HBPR and KCVD, in cooperation with the Inter-American Society of Hypertension.